Pooled patients treated with TTI-101 demonstrated a 9.4% decrease from baseline in fibrosis score at week 12, compared to a 2.4% decrease for the ...

Traditional trial start-up workflows often follow a sequential path, from feasibility to contracting, then regulatory ...

ASN Kidney Week, held in November, featured leading-edge science in kidney care, with evidence supporting new drugs to treat immunoglobulin A nephropathy, address chronic kidney disease in specific ...

Cumulus Neuroscience, a leading innovator in brain health technology for clinical trials, today announced the publication of ...

CMPS has benefited from positive phase 3 trial results and positive political developments since my last article. Click here ...

Radiopharmaceutical therapy (RPT) offers molecular-targeted treatment strategies and presents an ideal model for advancing ...

When a baby smiles at you, it's almost impossible not to smile back. This spontaneous reaction to a facial expression is part ...

The Food and Drug Administration (FDA) updated its guidance on Tuesday to allow more wearables to fall into a general ...

The cell and gene therapy market is at a pivotal point, with a surge in approvals and a maturing pipeline. While oncology ...

Polyrizon Ltd. Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal protective solutions today announced positive results from ...

New genetic research has identified a direct causal chain connecting the microorganisms in the human digestive tract to the ...

The Global Vagus Nerve Stimulation Market Size projected to grow at a CAGR of 10.50% from 2024 to 2031, according to a new ...